Estrogen action in mood and neurodegenerative disorders: Estrogenic compounds with selective properties - The next generation of therapeutics

Endocrine

Volumn 28, Issue 3, 2005, Pages 235-241

  Österlund, Marie K ^a   Witt, Michael Robin ^a   Gustafsson, Jan Åke ^b  

^a Karo Bio   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

17 estradiol; Affective disorders; Alzheimer's disease; Anxiety; Depression; Estrogen receptor; Neuroprotection

Indexed keywords

CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; ESTRADIOL; ESTRADIOL VALERATE; ESTROGEN; ESTROGEN RECEPTOR BETA; FULVESTRANT; NICOTINAMIDE ADENINE DINUCLEOTIDE; PROPYLPYRAZOLE TRIOL; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANXIETY; ANXIETY DISORDER; CENTRAL NERVOUS SYSTEM; CLIMACTERIUM; CORRELATION ANALYSIS; DEGENERATIVE DISEASE; DEPRESSION; ESTROGEN ACTIVITY; HORMONE ACTION; HORMONE DETERMINATION; MAMMAL; MENSTRUAL CYCLE; MOOD; MOOD DISORDER; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PUERPERIUM; REVIEW;

EID: 29944437975     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1385/ENDO:28:3:235     Document Type: Review

References (127)

1. Kuiper, G. G., Enmark, E., Pelto-Huikko, M., Nilsson, S., and Gustafsson, J.-A. (1996). Proc. Natl. Acad. Sci. USA 93(12), 5925-5930.
2. Imamov, O., Morani, A., Shim, G. J., Omoto, Y., Thulin-Andersson, C., Warner, M., and Gustafsson, J.-A. (2004). Proc. Natl. Acad. Sci. USA 101(25), 9375-9380.
3. Cheng, G., Weihua, Z., Makinen, S., et al. (2002). Biol. Reprod. 66(1), 77-84.
4. Wang, L., Andersson, S., Warner, M., and Gustafsson, J.-A. (2001). Proc. Natl. Acad. Sci. USA 98(5), 2792-2796.
5. Wang, L., Andersson, S., Warner, M., and Gustafsson, J.-A. (2002). Sci. STKE 2002(138), PE29.
6. Wang, L., Andersson, S., Warner, M., and Gustafsson, J.-A. (2003). Proc. Natl. Acad. Sci. USA 100(2), 703-708.
7. Riecher-Rossler, A. and Hafner, H. (1993). Eur. Arch. Psychiatry Clin. Neurosci. 242(6), 323-328.
8. Seeman, M. V. (1996). J. Psychiatry Neurosci. 21(2), 123-127.
9. Grigoriadis, S. and Seeman, M. V. (2002). Can. J. Psychiatry 47(5), 437-442.
10. Weissman, M. M., Bland, R., Joyce, P. R., Newman, S., Wells, J. E., and Wittchen, H. U. (1993). J. Affect. Disord. 29(2-3), 77-84.
11. Kessler, R. C., McGonagle, K. A., Zhao, S., et al. (1994). Arch. Gen. Psychiatry 51(1), 8-19.
12. Yonkers, K. A. (1997). J. Clin. Psychiatry 58(Suppl. 15), 19-25.
13. Hendrick, V., Altshuler, L. L., and Suri, R. (1998). Psychosomatics 39(2), 93-101.
14. Gale, S. and Harlow, B. L. (2003). J. Psychosom. Obstet. Gynaecol. 24(4), 257-266.
15. Campbell, S. B. and Cohn, J. F. (1991). J. Abnorm. Psychol. 100(4), 594-599.
16. Robinson, G. E. and Stewart, D. E. (1986). CMAJ 134(1), 31-37.
17. Pigott, T. A. (1999). J. Clin. Psychiatry 60(Suppl. 18), 4-15.
18. Kumar, R. and Robson, K. M. (1984). Br. J. Psychiatry 144, 35-47.
19. Payne, J. L. (2003). Int. Rev. Psychiatry 15(3), 280-290.
20. Cox, J. L., Murray, D., and Chapman, G. (1993). Br. J. Psychiatry 163, 27-31.
21. Cooper, P. J., Campbell, E. A., Day, A., Kennerley, H., and Bond, A. (1988). Br. J. Psychiatry 152, 799-806.
22. McKinlay, S. M., Brambilla, D. J., and Posner, J. G. (1992). Maturitas 14(2), 103-115.
23. Kessler, R. C., McGonagle, K. A., Swartz, M., Blazer, D. G., and Nelson, C. B. (1993). J. Affect. Disord. 29(2-3), 85-96.
24. Schmidt, P. J., Roca, C. A., Bloch, M., and Rubinow, D. R. (1997). Semin. Reprod. Endocrinol. 15(1), 91-100.
25. Hay, A. G., Bancroft, J., and Johnstone, E. C. (1994). Br. J. Psychiatry 164(4), 513-516.
26. Stewart, D. E., Boydell, K., Derzko, C., and Marshall, V. (1992). Int. J. Psychiatry Med. 22(3), 213-220.
27. Schmidt, P. J., Haq, N., and Rubinow, D. R. (2004). Am. J. Psychiatry 161(12), 2238-2244.
28. Grigoriadis, S. and Kennedy, S. H. (2002). Am. J. Ther. 9(6), 503-509.
29. Herva, A., Jokelainen, J., Pouta, A., et al. (2004). J. Psychosom. Res. 57(4), 359-362.
30. Epperson, C. N., Wisner, K. L., and Yamamoto, B. (1999). Psychosom. Med. 61(5), 676-697.
31. Gregoire, A. J., Kumar, R., Everitt, B., Henderson, A. F., and Studd, J. W. (1996). Lancet 347(9006), 930-933.
32. Ahokas, A., Kaukoranta, J., Wahlbeck, K., and Aito, M. (2001). J. Clin. Psychiatry 62(5), 332-336.
33. Sichel, D. A., Cohen, L. S., Robertson, L. M., Ruttenberg, A., and Rosenbaum, J. F. (1995). Biol. Psychiatry 38(12), 814-818.
34. Strickler, R. C., Borth, R., Cecutti, A., et al. (1977). Psychol. Med. 7(4), 631-639.
35. Morrison, M. F., Kallan, M. J., Ten Have, T., Katz, I., Tweedy, K., and Battistini, M. (2004). Biol. Psychiatry 55(4), 406-412.
36. Hays, J., Ockene, J. K., Brunner, R. L., et al. (2003). N. Engl. J. Med. 348(19), 1839-1854.
37. Whooley, M. A., Grady, D., and Cauley, J. A. (2000). J. Gen. Intern. Med. 15(8), 535-541.
38. Palinkas, L. A. and Barrett-Connor, E. (1992). Obstet. Gynecol. 80(1), 30-36.
39. Hlatky, M. A., Boothroyd, D., Vittinghoff, E., Sharp, P., and Whooley, M. A. (2002). JAMA 287(5), 591-597.
40. Schiff, R., Bulpitt, C. J., Wesnes, K. A. and Rajkumar, C. (2005). Psychoneuroendocrinology 30(4), 309-315.
41. Schmidt, P. J., Nieman, L., Danaceau, M. A., et al. (2000). Am. J. Obstet. Gynecol. 183(2), 414-420.
42. Soares, C. N., Almeida, O. P., Joffe, H., and Cohen, L. S. (2001). Arch. Gen. Psychiatry 58(6), 529-534.
43. Rossouw, J. E., Anderson, G. L., Prentice, R. L., et al. (2002). JAMA 288(3), 321-333.
44. Stewart, D. E., Rolfe, D. E., and Robertson, E. (2004). Psychosomatics 45(5), 445-447.
45. Couse, J. F., Lindzey, J., Grandien, K., Gustafsson, J.-A., and Korach, K. S. (1997). Endocrinology 138(11), 4613-4621.
46. Kuiper, G., Carlsson, G., Grandien, B., et al. (1997). Endocrinology 138(3), 863-870.
47. Osterlund, M. K., Gustafsson, J.-A., Keller, E., and Hurd, Y. L. (2000). J. Clin. Endocrinol. Metab. 85(10), 3840-3846.
48. Harris, H. A., Katzenellenbogen, J. A., and Katzenellenbogen, B. S. (2002). Endocrinology 143(11), 4172-4177.
49. Lund, T. D., Rovis, T., Chung, W. C., and Handa, R. J. (2005). Endocrinology 146(2), 797-807.
50. Walf, A. A., Rhodes, M. E., and Frye, C. A. (2004). Pharmacol. Biochem. Behav. 78(3), 523-529.
51. Meyers, M. J., Sun, J., Carlson, K. E., Marriner, G. A., Katzenellenbogen, B. S., and Katzenellenbogen, J. A. (2001). J. Med. Chem. 44(24), 4230-4251.
52. Stauffer, S. R., Coletta, C. J., Tedesco, R., et al. (2000). J. Med. Chem. 43(26), 4934-4947.
53. Rocha, B. A., Fleischer, R., Schaeffer, J. M., Rohrer, S. P., and Hickey, G. J. (2005). Psychopharmacology (Berl.) 179(3), 637-643.
54. Bethea, C. L., Mirkes, S. J., Shively, C. A., and Adams, M. R. (2000). Biol. Psychiatry 47(6), 562-576.
55. Fink, G., Sumner, B. E., Rosie, R., Grace, O., and Quinn, J. P. (1996). Cell. Mol. Neurobiol. 16(3), 325-344.
56. Lu, N. Z., Shlaes, T. A., Gundlah, C., Dziennis, S. E., Lyle, R. E., and Bethea, C. L. (1999). Endocrine 11(3), 257-267.
57. Osterlund, M. K., Halldin, C., and Hurd, Y. L. (2000). Synapse 35(1), 39-44.
58. Osterlund, M. K. and Hurd, Y. L. (1998). Brain Res. Mol. Brain Res. 55(1), 169-172.
59. Gundlah, C., Alves, S. E., Clark, J. A., Pai, L. Y., Schaeffer, J. M., and Rohrer, S. P. (2005). Biol. Psychiatry 57(8), 938-942.
60. Nomura, M., Akama, K. T., Alves, S. E., et al. (2005). Neuroscience 130(2), 445-456.
61. Walther, D. J., Peter, J. U., Bashammakh, S., et al. (2003). Science 299(5603), 76.
62. Clark, J. A., Pai, L. Y., Flick, R. B., and Rohrer, S. P. (2005). Biol. Psychiatry 57(8), 943-946.
63. Sanchez, R. L., Reddy, A. P., Centeno, M. L., Henderson, J. A., and Bethea, C. L. (2005). Brain Res. Mol. Brain Res. 135(1-2), 194-203.
64. Krezel, W., Dupont, S., Krust, A., Chambon, P., and Chapman, P. F. (2001). Proc. Natl. Acad. Sci. USA 98(21), 12278-12282.
65. Imwalle, D. B., Gustafsson, J.-A., and Rissman, E. F. (2005). Physiol. Behav. 84(1), 157-163.
66. Lee, S. J. and McEwen, B. S. (2001). Ann. Rev. Pharmacol. Toxicol. 41, 569-591.
67. Selkoe, D. J. and Schenk, D. (2003). Ann. Rev. Pharmacol. Toxicol. 43, 545-584.
68. Roth, M. P., Clayton, J., Patois, E., and Alperovitch, A. (1994). Neuroepidemiology 13, 211-215.
69. Saunders-Pullman, R., Gordon-Elliott, J., Parides, M., Fahn, S., Saunders, H. R., and Bressman, S. (1999). Neurology 52(7), 1417-1421.
70. Atwood, C. S. (2005). Cell. Mol. Life Sci. 62(3), 255-256.
71. Alkayed, N. J., Harukuni, I., Kimes, A. S., London, E. D., Traystman, R. J., and Hurn, P. D. (1998). Stroke 29(1), 159-165; discussion 166.
72. Culmsee, C., Vedder, H., Ravati, A., et al. (1999). J. Cereb. Blood Flow Metab. 19(11), 1263-1269.
73. McEwen, B. (2002). Recent Prog. Horm. Res. 57, 357-384.
74. Sherwin, B. B. (2003). J. Mol. Neurosci. 20(3), 385-393.
75. Matsumoto, A. and Arai, Y. (1981). J. Comp. Neurol. 197(2), 197-205.
76. Singh, M., Setalo, G. Jr., Guan, X., Warren, M., and Toran-Allerand, C. D. (1999). J. Neurosci. 19(4), 1179-1188.
77. Toran-Allerand, C. D. (2004). Endocrinology 145(3), 1069-1074.
78. Toran-Allerand, C. D., Guan, X., MacLusky, N. J., et al.(2002). J. Neurosci. 22(19), 8391-8401.
79. Green, P. S., Yang, S. H., and Simpkins, J. W. (2000). Novartis Found Symp. 230, 202-213.
80. Marin, R., Guerra, B., Morales, A., Diaz, M., and Alonso, R. (2003). Ann. NY Acad. Sci. 1007, 108-116.
81. Krishnan, K., Campbell, S., Abdel-Rahman, F., Whaley, S., and Stone, W. L. (2003). Curr. Drug Targets 4(1), 45-54.
82. Simpkins, J. W., Yang, S. H., Wen, Y., and Singh, M. (2005). Cell. Mol. Life Sci. 62(3), 271-280.
83. Behl, C. and Moosmann, B. (2002). Biol. Chem. 383(3-4), 521-536.
84. Rao, A. V. and Balachandran, B. (2002). Nutr. Neurosci. 5(5), 291-309.
85. Behl, C., Widmann, M., Trapp, T., and Holsboer, F. (1995). Biochem. Biophys. Res. Commun. 216(2), 473-482.
86. Chaban, V. V., Mayer, E. A., Ennes, H. S., and Micevych, P. E. (2003). Neuroscience 118(4), 941-948.
87. Mermelstein, P. G., Becker, J. B., and Surmeier, D. J. (1996). J. Neurosci. 16(2), 595-604.
88. Lewen, A., Matz, P., and Chan, P. H. (2000). J. Neurotrauma 17(10), 871-890.
89. Bayir, H., Marion, D. W., Puccio, A. M., et al. (2004). J. Neurotrauma 21(1), 1-8.
90. Sekhon, L. H. and Fehlings, M. G. (2001). Spine 26(24 Suppl.), S2-12.
91. Singer, C. A., Figueroa-Masot, X. A., Batchelor, R. H., and Dorsa, D. M. (1999). J. Neurosci. 19(7), 2455-2463.
92. Jover, T., Tanaka, H., Calderone, A., et al. (2002). J. Neurosci. 22(6), 2115-2124.
93. Koski, C. L., Hila, S., and Hoffman, G. E. (2004). Endocrinology 145(1), 95-103.
94. Jung, Y. S., Lee, B. K., Park, H. S., et al. (2005). Neuroreport 16(7), 741-744.
95. Ospina, J. A., Brevig, H. N., Krause, D. N., and Duckles, S. P. (2004). Am. J. Physiol. Heart Circ. Physiol. 286(5), H2010-H2019.
96. Vegeto, E., Belcredito, S., Etteri, S., et al. (2003). Proc. Natl. Acad. Sci. USA 100(16), 9614-9619.
97. Polanczyk, M., Zamora, A., Subramanian, S., et al. (2003). Am. J. Pathol. 163(4), 1599-1605.
98. Fridmacher, V., Kaltschmidt, B., Goudeau, B., et al. (2003). J. Neurosci. 23(28), 9403-9408.
99. Castagne, V., Lefevre, K., and Clarke, P. G. (2001). Neuroscience 108(3), 517-526.
100. O'Neill, L. A. and Kaltschmidt, C. (1997). Trends Neurosci. 20, 252-258.
101. Ghisletti, S., Meda, C., Maggi, A., and Vegeto, E. (2005). Mol. Cell. Biol. 25(8), 2957-2968.
102. Dodel, R. C., Du, Y., Bales, K. R., Gao, F., and Paul, S. M. (1999). J. Neurochem. 73(4), 1453-1460.
103. Harnish, D. C., Scicchitano, M. S., Adelman, S. J., Lyttle, C. R., and Karathanasis, S. K. (2000). Endocrinology 141, 3403-3411.
104. Speir, E., Yu, Z. X., Takeda, K., Ferrans, V. J., and Cannon, R. O. 3rd (2000). Circulation 102(24), 2990-2996.
105. Jaffe, A. B., Toran-Allerand, C. D., Greengard, P., and Gandy, S. E. (1994). J. Biol. Chem. 269(18), 13,065-13,068.
106. Greenfield, J. P., Leung, L. W., Cai, D., et al. (2002). J. Biol. Chem. 277(14), 12128-12136.
107. Li, R., Shen, Y., Yang, L. B., Lue, L. F., Finch, C., and Rogers, J. (2000). J. Neurochem. 75(4), 1447-1454.
108. Xu, H., Gouras, G. K., Greenfield, J. P., et al. (1998). Nat. Med. 4(4), 447-451.
109. Kugaya, A., Epperson, C. N., Zoghbi, S., et al. (2003). Am. J. Psychiatry 160(8), 1522-1524.
110. Duka, T., Tasker, R., and McGowan, J. F. (2000). Psychopharmacology (Berl.) 149(2), 129-139.
111. Hogervorst, E., Boshuisen, M., Riedel, W., Willeken, C., and Jolles, J. (1999). Psychoneuroendocrinology 24(1), 43-68.
112. Sherwin, B. B. (1988). Psychoneuroendocrinology 13(4), 345-357.
113. Phillips, S. M. and Sherwin, B. B. (1992). Psychoneuroendocrinology 17(5), 485-495.
114. Saletu, B. (2003). Climacteric 6(Suppl. 2), 37-45.
115. Anderson, G. L., Limacher, M., Assaf, A. R., et al. (2004). JAMA 291(14), 1701-1712.
116. Lacey, J. V. Jr., Mink, P. J., Lubin, J. H., et al. (2002). JAMA 288(3), 334-341.
117. Rapp, S. R., Espeland, M. A., Shumaker, S. A., et al. (2003). JAMA 289(20), 2663-2672.
118. Shumaker, S. A., Legault, C., Rapp, S. R., et al. (2003). JAMA 289(20), 2651-2662.
119. Wise, P. M., Dubal, D. B., Rau, S. W., Brown, C. M., and Suzuki, S. (2005). Endocr. Rev. 26, 308-312.
120. Hersh, A. L., Stefanick, M. L., and Stafford, R. S. (2004). JAMA 291(1), 47-53.
121. Bhavnani, B. R. (2003). J. Steroid Biochem. Mol. Biol. 85 (2-5), 473-482.
122. Bhavnani, B. R., Nisker, J. A., Martin, J., Aletebi, F., Watson, L., and Milne, J. K. (2000). J. Soc. Gynecol. Investig. 7(3), 175-183.
123. Honjo, H., Ogino, Y., Tanaka, K., Urabe, M., Kashiwagi, T., and Ishihara, S. (1993). J. Jap. Mneop. Soc. 1, 167-171.
124. Asthana, S., Craft, S., Baker, L. D., et al. (1999). Psychoneuroendocrinology 24(6), 657-677.
125. Asthana, S., Baker, L. D., Craft, S., et al. (2001). Neurology 57(4), 605-612.
126. Gleason, C. F., Cholerton, B., Carlsson, C. M., Johnson, S. C., and Asthana, S. (2005). Cell. Mol. Life Sci. 62(3), 299-312.
127. Resnick, S. M. and Maki, P. M. (2001). Ann. NY Acad. Sci. 949, 203-214.